Cargando…

Respiratory Syncytial Virus Infection Morbidity in the Elderly: Time for Repurposing of Ribavirin?

Detalles Bibliográficos
Autores principales:	de Zwart, Auke E S, Riezebos-Brilman, Annelies, Kerstjens, Huib A M, Verschuuren, Erik A M, Alffenaar, Jan-Willem C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108197/ https://www.ncbi.nlm.nih.gov/pubmed/31504299 http://dx.doi.org/10.1093/cid/ciz835

Ejemplares similares

Respiratory Syncytial Virus, Human Metapneumovirus, and Parainfluenza Virus Infections in Lung Transplant Recipients: A Systematic Review of Outcomes and Treatment Strategies
por: de Zwart, Auke, et al.
Publicado: (2021)

Evaluation of 10 years of parainfluenza virus, human metapneumovirus, and respiratory syncytial virus infections in lung transplant recipients
por: de Zwart, Auke E. S., et al.
Publicado: (2020)

Impact of COVID-19 social distancing measures on lung transplant recipients: decline in overall respiratory virus infections is associated with stabilisation of lung function
por: de Zwart, Auke E.S., et al.
Publicado: (2022)

RIBAVIRIN AND RESPIRATORY SYNCYTIAL VIRUS
Publicado: (1986)

Rapid Molecular Tests for Influenza, Respiratory Syncytial Virus, and Other Respiratory Viruses: A Systematic Review of Diagnostic Accuracy and Clinical Impact Studies
por: Vos, Laura M, et al.
Publicado: (2019)

Broad Decline in Viral Infections During COVID-19 Lockdown: Association with Lung Function in Lung Transplant Recipients
por: de Zwart, A.E., et al.
Publicado: (2022)

Sofosbuvir Add-on to Ribavirin Treatment for Chronic Hepatitis E Virus Infection in Solid Organ Transplant Recipients Does Not Result in Sustained Virological Response
por: van Wezel, E M, et al.
Publicado: (2019)

Successful Treatment of Respiratory Syncytial Virus Infection in an Immunocompromised Patient With Ribavirin
por: Mir, Wasey Ali Yadullahi, et al.
Publicado: (2021)

Respiratory syncytial virus: paying the immunity debt with interest
por: Hatter, Lee, et al.
Publicado: (2021)

1600. An Optimal Respiratory Syncytial Virus (RSV) Treatment in Lung Transplant Recipients: Oral Ribavirin, Inhaled Ribavirin, or Conservative Approach
por: Permpalung, Nitipong, et al.
Publicado: (2018)

Tissue is the issue: a solitary cerebral lesion 15 years after kidney transplantation
por: de Joode, Anoek A. E., et al.
Publicado: (2011)

COVID-19 public health measures and respiratory syncytial virus
por: Britton, Philip N, et al.
Publicado: (2020)

Whole blood gene expression in infants with respiratory syncytial virus bronchiolitis
por: Fjaerli, Hans-Olav, et al.
Publicado: (2006)

Influenza and respiratory syncytial virus interbreed: Engendering a novel deadly virus
por: Amin, Ruhul, et al.
Publicado: (2023)

More targeted use of oseltamivir and in-hospital isolation facilities after implementation of a multifaceted strategy including a rapid molecular diagnostic panel for respiratory viruses in immunocompromised adult patients
por: Vos, Laura M., et al.
Publicado: (2019)

Broad Virus Detection and Variant Discovery in Fecal Samples of Hematopoietic Transplant Recipients Using Targeted Sequence Capture Metagenomics
por: Jansen, Suze A., et al.
Publicado: (2020)

SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses
por: Swets, Maaike C, et al.
Publicado: (2022)

Revitalizing hope for older adults: The use of the novel Arexvy for immunization against respiratory syncytial virus
por: Abbasi, Haleema Q., et al.
Publicado: (2023)

Improved diagnostic policy for respiratory tract infections essential for patient management in the emergency department
por: Poelman, Randy, et al.
Publicado: (2020)

Respiratory Syncytial Virus Infection in Elderly Adults
por: Falsey, Ann R., et al.
Publicado: (2012)

2787. Respiratory Syncytial Virus in Elderly Adults
por: Mykietiuk, Analía, et al.
Publicado: (2019)

Investigating the Influence of Ribavirin on Human Respiratory Syncytial Virus RNA Synthesis by Using a High-Resolution Transcriptome Sequencing Approach
por: Aljabr, Waleed, et al.
Publicado: (2016)

A delicate balance between rejection and BK polyomavirus associated nephropathy; A retrospective cohort study in renal transplant recipients
por: Gard, Lilli, et al.
Publicado: (2017)

Fruit fly for anticancer drug discovery and repurposing
por: Nainu, Firzan, et al.
Publicado: (2023)

The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood
por: Fauroux, Brigitte, et al.
Publicado: (2017)

Respiratory syncytial virus pneumonia in a LDLT recipient transplanted for COVID 19 precipitated ACLF: Treated with ribavirin and IVIg
por: Kapoor, Sorabh, et al.
Publicado: (2022)

Repurposing existing drugs for COVID-19: an endocrinology perspective
por: Cadegiani, Flavio A.
Publicado: (2020)

Respiratory syncytial virus infection: a new threat of public health, epidemiology, pathogenesis, genomic characteristics, and current status
por: Akash, Shopnil, et al.
Publicado: (2023)

Optimizing Antimicrobial and Host-Directed Therapies to Improve Clinical Outcomes of Childhood Tuberculous Meningitis( )
por: Gafar, Fajri, et al.
Publicado: (2021)

Respiratory syncytial virus‐associated acute respiratory illness in adult non‐immunocompromised patients: Outcomes, determinants of outcomes, and the effect of oral ribavirin treatment
por: Wongsurakiat, Phunsup, et al.
Publicado: (2022)

Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol
por: Zeng, Yan-Ming, et al.
Publicado: (2020)

Repurposed GI Drugs in the Treatment of COVID-19
por: Aguila, Enrik John T., et al.
Publicado: (2020)

Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly
por: Blanco, Jorge C. G., et al.
Publicado: (2023)

Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication
por: Tripp, Ralph A., et al.
Publicado: (2022)

Possible therapeutic effect of orally administered ribavirin for respiratory syncytial virus-induced acute respiratory distress syndrome in an immunocompetent patient: a case report
por: Yoon, Byung Woo, et al.
Publicado: (2017)

Relevance of the drug–drug interactions between lidocaine and the pharmacokinetic enhancers ritonavir and cobicistat
por: Dekkers, Bart G.J., et al.
Publicado: (2019)

Erratum: Effect of Prophylactic Palivizumab on Admission Due to Respiratory Syncytial Virus Infection in Former Very Low Birth Weight Infants with Bronchopulmonary Dysplasia
Publicado: (2016)

Repurposing Dimetridazole and Ribavirin to disarm Pseudomonas aeruginosa virulence by targeting the quorum sensing system
por: Yuan, Yang, et al.
Publicado: (2022)

Repurposing cholesterol lowering drugs in the treatment and management of monkeypox
por: Sekaran, Saravanan, et al.
Publicado: (2023)

Repurposing Polyvinyl Chloride Pipes in the Emergency Department for COVID-19
por: Deng, Wei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f4sg272gtnell4bv5t7fm8tc4s